Women undergo important changes in sex hormones throughout their lifetime that can
impact cardiovascular disease risk. Whereas the traditional cardiovascular risk factors …

Menopause hormone therapy (MHT) is the most efficient treatment for symptoms of acute
climacteric syndrome and for efficient prevention of long-term estrogen deficiency. Vaginal …

Wytyczne dotyczące nadciśnienia tętniczego opublikowane w 2013 r. przez Europejskie
Towarzystwo Nadciśnienia Tętniczego (ESH) i Europejskie Towarzystwo Kardiologiczne …

Guía de práctica clínica de la Sociedad Interamericana de Cardiología sobre prevención
primaria de enfermedad cardiovascular en la mujer SciELO - Scientific Electronic Library …

A recent report of the EuroHeart project has shown that women are still underrepresented in
many cardiovascular clinical trials, while important gender differences are present within …

The incidence of metabolic syndrome increases substantially during perimenopause and
early menopause. Postmenopausal women are at a higher risk of hypertension …

Hypertension in women is often undiagnosed or inade-quately treated, especially after
menopause when cardiovascular risk increases. In premenopausal women, endogenous …

Importance Vasomotor symptoms (hot flushes and night sweats) and other symptoms,
including depression, anxiety and panic attacks, are commonly experienced by menopausal …

The role of dietary fat has been long studied as a modifiable variable in the prevention and
treatment of noncommunicable cardiometabolic disease. Once heavily promoted to the …

The mineralocorticoid receptor (MR) mediates aldosterone-and glucocorticoid-induced
adipocyte differentiation. Drospirenone (DRSP) is a potent synthetic antimineralocorticoid …